Marimed (MRMD) Cash from Investing Activities (2012 - 2026)

Marimed (MRMD) has reported Cash from Investing Activities for 15 consecutive years, with -$507000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 8.48% year-over-year to -$507000.0 in Q2 2026; TTM through Jun 2026 was -$2.0 million, a 50.64% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, up 91.95% from the prior year.
• Cash from Investing Activities was -$507000.0 for Q2 2026 at Marimed, up from -$753000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$115000.0 in Q1 2025 and troughed at -$16.7 million in Q2 2022.
• A 5-year average of -$4.0 million and a median of -$2.6 million in 2022 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities jumped 97.3% in 2025 and sank 554.78% in 2026, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$2.5 million in 2022, then sank by 152.61% to -$6.3 million in 2023, then jumped by 81.1% to -$1.2 million in 2024, then surged by 83.58% to -$197000.0 in 2025, then tumbled by 157.36% to -$507000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$507000.0 (Q2 2026), -$753000.0 (Q1 2026), and -$197000.0 (Q4 2025), per Business Quant data.